Enanta Pharmaceuticals Inc. (ENTA)
NASDAQ · Healthcare
Enanta Pharmaceuticals Inc. EPS 2020–2025
Enanta Pharmaceuticals Inc. annual/quarterly eps history and growth rate from 2020 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Enanta Pharmaceuticals Inc. eps for the quarter ending March 31, 2026 was $0.45, a 57.55% decrease year-over-year.
- Enanta Pharmaceuticals Inc. annual eps for 2025 was $3.84, a 29.93% decrease from 2024.
- Enanta Pharmaceuticals Inc. annual eps for 2024 was $5.48, a 14.11% decrease from 2023.
- Enanta Pharmaceuticals Inc. annual eps for 2023 was $6.38, a 7.95% increase from 2022.
- Enanta Pharmaceuticals Inc. annual eps for 2022 was $5.91.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Enanta Pharmaceuticals Inc. EPS — FAQ
Enanta Pharmaceuticals Inc. (ENTA) eps over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Enanta Pharmaceuticals Inc.'s eps?
Enanta Pharmaceuticals Inc. (ENTA) reported eps of $-3.84 for fiscal 2025.
Where can I see ENTA's eps history?
The chart and table above show Enanta Pharmaceuticals Inc.'s eps by year and by quarter, including the growth rate.